SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001527599-17-000011
Filing Date
2017-05-09
Accepted
2017-05-09 17:17:24
Documents
2
Period of Report
2017-05-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K EARNINGS RELEASE a8kprearningsq12017.htm 8-K 23493
2 EXHIBIT 99.1 EARNINGS RELEASE mirna-2017q1earningsrelease.htm EX-99.1 73271
  Complete submission text file 0001527599-17-000011.txt   97810
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 17827527
SIC: 2834 Pharmaceutical Preparations